Osaka-based Shinogi and Stamford’s Purdue Pharma have teamed up for the joint U.S. launch and commercialization of Symproic®, a novel peripherally-acting mu opioid receptor antagonist for the treatment of opioid-induced constipation in adults with chronic non-cancer pain … more

Purdue Pharma and Exicure have announced a strategic research collaboration and option and license agreement to discover and develop a treatment for psoriasis and other diseases amenable to a gene regulation approach utilizing Exicure’s Spherical Nucleic Acid (SNA)™ technology … ​more